Preclina Co., Ltd. (CEO Kang Young-mo) will participate in the ‘6 International Advanced Medical Equipment and Medical Industry Exhibition (KOAMEX 30)’ held at EXCO in Daegu for three days from June 7 (Fri) to July 2 (Sun). revealed
Pre-Clina is a non-clinical test service CRO with an integrated platform specialized in new drug development based on rich experience and expertise in patient-derived cell tests and animal model tests for autoimmune and inflammatory diseases.
At this exhibition, it will introduce a non-clinical efficacy evaluation service platform specializing in autoimmune and inflammatory diseases. As an efficacy evaluation service required for new drug development, it provides a verified animal model system for autoimmune diseases adopted by Global Pharma. In addition, experienced immunology researchers are conducting cell-based assays based on patient-derived (PreHuCel) and animal model-derived (PreExoCel) cell lines.
An official from Preclina said, “The goal is to efficiently reduce the high cost of evaluating the effectiveness of drug development for biopharmaceutical companies through test optimization.” I will do it,” he said.
“Mouse models are an important tool for conducting preclinical research and are increasingly used as models for biomedical research applications such as cancer, infectious diseases, HIV/AIDS, regenerative medicine and hepatitis,” he added. It is expected to witness the highest growth owing to increase in research activities. Accordingly, the company plans to build a PDX model using humanized mice and provide an efficacy evaluation service.”
Meanwhile, the main exhibition items of ‘KOAMEX 2023’ hosted by Daegu Metropolitan City and K-MEDI Hub are as follows. △Diagnostic and diagnostic devices such as scanners, measuring devices, and imaging devices △Clinical and inspection devices △Surgical and recycling devices △Hospital facilities and emergency equipment △Medical devices, parts, and services △Pharmaceutical devices △Medical services, SW